Disclosures for "A Cross-sectional Study of Plasma Aβ42/40 Ratio, pTau217, pTau181, GFAP and Nf-L in an Alzheimer’s Disease Clinical Cohort Characterized by Amyloid PET Imaging"
-
Dr. Winslow has received personal compensation for serving as an employee of Monogram Biosciences/Labcorp. Dr. Winslow has received intellectual property interests from a discovery or technology relating to health care.
-
Dr. Chenna has received personal compensation for serving as an employee of LabCorp-monogram Biosciences.
-
Youssouf Badal has nothing to disclose.
-
-
Mr. Yee has received personal compensation for serving as an employee of Monogram Biosciences/LabCorp. Mr. Yee has stock in LabCorp.
-
Mr. Lim has received personal compensation for serving as an employee of Monogram Labcorp.
-
Dr. Jeromin has received personal compensation for serving as an employee of AlzPath, Inc. Dr. Jeromin has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Quanterx.
-
-
Mr. Martone has received personal compensation for serving as an employee of Labcorp. Mr. Martone has stock in Pfizer. Mr. Martone has stock in AbbVie. Mr. Martone has stock in Labcorp.
-
Dr. Petropoulos has received personal compensation for serving as an employee of Monogram Biosciences-Labcorp. Dr. Petropoulos has received stock or an ownership interest from Laboratory Corporation of America Holdings. Dr. Petropoulos has received intellectual property interests from a discovery or technology relating to health care.